MAPT and Alzheimer disease: It is without question, however, that both characteristic proteinopathies are necessary for the current characterization of the disease, which stresses an issue with the most basic familial AD mouse models: mouse models, whether they express a singular mutation or overexpress multiple familial AD mutations, do not develop subsequent tau pathology [193, 196].